Yasunori Suzuki Selected Research

spleen fibrinolytic proteinase (human) (SFP)

12/2020	A novel staphylococcal enterotoxin SE02 involved in a staphylococcal food poisoning outbreak that occurred in Tokyo in 2004.
11/2018	Development of an Immunoassay for Detection of Staphylococcal Enterotoxin-Like J, A Non-Characterized Toxin.
8/2015	Detection of the staphylococcal enterotoxin D-like gene from staphylococcal food poisoning isolates over the last two decades in Tokyo.
10/2014	Molecular epidemiological characterization of Staphylococcus aureus isolates originating from food poisoning outbreaks that occurred in Tokyo, Japan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasunori Suzuki Research Topics

Disease

5	Immunoglobulin G4-Related Disease 01/2018 - 01/2011
4	Staphylococcal Food Poisoning 12/2020 - 10/2014
3	Infections 01/2022 - 01/2021
3	Foodborne Diseases 12/2017 - 10/2014
2	Neoplasms (Cancer) 09/2022 - 01/2011
2	Pneumonia (Pneumonitis) 06/2022 - 01/2021
2	Lymphadenopathy 01/2020 - 07/2015
2	Fibrosis (Cirrhosis) 01/2018 - 01/2011
2	Bites and Stings (Sting) 02/2015 - 10/2012
1	Rheumatoid Arthritis 02/2022
1	Disease Progression 01/2022
1	Mixed Connective Tissue Disease (MCTD) 01/2022
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2022
1	Dry Eye Syndromes (Dry Eye Syndrome) 10/2021
1	Bone Resorption 02/2021
1	Central Nervous System Infections (Central Nervous System Infection) 01/2021
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2018
1	Inflammation (Inflammations) 01/2018
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2018
1	Radicular Cyst 01/2018
1	Salivary Gland Calculi (Sialolithiasis) 01/2018
1	Body Weight (Weight, Body) 09/2017
1	Systemic Scleroderma (Systemic Sclerosis) 01/2017
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 07/2015
1	Polyarteritis Nodosa (Periarteritis Nodosa) 09/2013
1	Hepatitis B 09/2013
1	Gingival Hypertrophy 01/2012
1	Skin Manifestations 01/2011
1	Hyperalgesia 01/2002
1	Acute Pain 01/2002

Drug/Important Bio-Agent (IBA)

4	Enterotoxins (Enterotoxin)IBA 12/2020 - 10/2014
4	spleen fibrinolytic proteinase (human) (SFP)IBA 12/2020 - 10/2014
3	Immunoglobulin G (IgG)IBA 01/2018 - 01/2011
2	OligonucleotidesIBA 09/2022 - 08/2021
2	Proteins (Proteins, Gene)FDA Link 12/2020 - 12/2017
2	GlucocorticoidsIBA 01/2018 - 09/2017
1	MicroRNAs (MicroRNA)IBA 09/2022
1	Therapeutic UsesIBA 09/2022
1	Staphylococcal Protein A (Protein A)IBA 06/2022
1	Abatacept (Orencia)FDA Link 02/2022
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	AntibodiesIBA 10/2021
1	Biological ProductsIBA 01/2020
1	Tyrosine (L-Tyrosine)FDA Link 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	CollagenIBA 01/2018
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2018
1	Hematoxylin (Haematoxylon)IBA 01/2018
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2018
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2018
1	SteroidsIBA 01/2018
1	Prednisolone (Predate)FDA LinkGeneric 09/2017
1	anticentromere antibodyIBA 01/2017
1	Staphylococcal enterotoxin DIBA 08/2015
1	EmeticsIBA 08/2015
1	Immunoglobulins (Immunoglobulin)IBA 07/2015
1	TinIBA 07/2015
1	Etanercept (Enbrel)FDA Link 09/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2013
1	Nifedipine (Adalat)FDA LinkGeneric 01/2012
1	Immunoglobulin E (IgE)IBA 01/2011
1	AntigensIBA 01/2011
1	N- (4- amino- 2- methylquinolin- 6- yl)- 2- (4- ethylphenoxymethyl)benzamideIBA 01/2002
1	NociceptinIBA 01/2002

Therapy/Procedure

2	Therapeutics 09/2022 - 01/2011
2	Prostheses and Implants (Prosthesis) 02/2015 - 10/2012
1	Molecular Targeted Therapy 09/2022
1	Overlay Denture 02/2021
1	Kidney Transplantation 01/2021
1	Bite Force (Occlusal Forces) 02/2015
1	Peritoneal Dialysis 01/2011
1	Oral Administration 01/2002
1	Intravenous Injections 01/2002